Active Funding Opportunity Announcements (FOAs) for All NICHD

NICHD issues and participates in various FOAs to support research activities and training.

Investigator-Initiated (Unsolicited) Projects

To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.

Active FOAs for NICHD

Please note: The following FOAs are sorted by date, from most recent to oldest. Select a table heading to change how to sort and display the FOAs.

Announcement Number Submissions Date(s) Expiration Date Activity Code(s) Title
RFA-MH-19-136 September 27, 2018; September 6, 2019; September 9,2020
, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
September 10, 2020 R01 BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
PAR-18-766 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
September 8, 2021 R01 Identification and Management of Behavioral Symptoms and Mental Health Conditions in Individuals with Intellectual Disabilities (R01 - Clinical Trial Optional)
RFA-NS-18-030 July 3, 2018; N?o?v?e?m?b?e?r? ?6, 2018; July 3, 2019; November 6, 2019; July 1, 2020; November 10, 2020by 5:00 PM local time of applicant organization.All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. November 11, 2020 R01 BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed)
PAR-18-745 June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020 and November 13, 2020 by 5:00 PM local time of applicant organization. November 14, 2020 R21 Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)
PAR-18-747 June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020, November 13, 2020 by 5:00 PM local time of applicant organization. November 14, 2020 R01 Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional)
PA-18-728 Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2021 R21 Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)
PA-18-729 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2021 R01 Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional)
PA-18-720 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2021 R21 Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional)
PAR-18-714 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2021 R15 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
RFA-NS-18-019 May 15, 2018, November 27, 2018, May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
October 30, 2020 U01 BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01-Clinical Trials Not Allowed)
RFA-NS-18-020 May 15, 2018, November 27, 2018, May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
October 30, 2020 R01 BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trials Not Allowed)
RFA-EY-18-001 May 1, 2018, November 27, 2018, May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
October 30, 2020 R21 BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
PA-18-688 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2021 R01 Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R01 Clinical Trial Optional)
PAR-18-691 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2021 R21 Innovative Therapies and Tools for Screenable Disorders (R21 Clinical Trial Optional)
PAR-18-689 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2021 R01 Innovative Therapies and Tools for Screenable Disorders (R01 Clinical Trial Optional)
PA-18-687 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2021 R03 Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R03 Clinical Trial Optional)
PAR-18-690 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2021 R03 Innovative Therapies and Tools for Screenable Disorders (R03 Clinical Trial Optional)
PA-18-648 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. January 8, 2021 R13 NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
PA-18-589 A successor-in-interest request must be made before the anticipated start date at the new organization and preferably several months in advance. January 26, 2021 666 Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
PA-18-590 A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance. January 26, 2021 777 Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
top of pageBACK TO TOP